Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

Joel Goldstein, PhD

Joel Goldstein, PhD is associate director, transfectoma development, at Medarex Inc.

Articles by Joel Goldstein, PhD

The Impact of Cell Culture Medium on Cell Line and Process Development Timelines and Strategies

ByClaudia Kloth, PhD,Haile Ghebremariam,Joel Goldstein, PhD,Xiao-Ping Dai, PhD,Glenn MacIsaac,Melissa Wagner,Alahari Arunakumari, PhD

June 2nd 2009

ACF medium sped up cell-line development.

Latest Updated Articles

The Impact of Cell Culture Medium on Cell Line and Process Development Timelines and Strategies
June 2nd 2009

Trending on BioPharm International

AstraZeneca Acquires Omniose, Adding Bioconjugate Vaccine Platform

Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial

ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months

The BioPharm Brief: FDA Designations for a Bispecific CAR-T, a BLA for Friedreich’s Ataxia, and Phase 2b MASH Data for Efinopegdutide

Efinopegdutide Meets Primary Endpoint in Phase 2b MASH Trial